These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1948124)

  • 1. Clinical trials of alpha-interferon in the treatment of non-Hodgkin's lymphoma.
    Gaynor ER; Fisher RI
    Semin Oncol; 1991 Oct; 18(5 Suppl 7):12-7. PubMed ID: 1948124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current and future uses of recombinant interferon alpha in the treatment of low-grade non-Hodgkin's lymphoma.
    Steis RG; Foon KA; Longo DL
    Cancer; 1987 Feb; 59(3 Suppl):658-63. PubMed ID: 10822466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintenance of remission with human recombinant interferon alfa-2a in patients with stages III and IV low-grade malignant non-Hodgkin's lymphoma. European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group.
    Hagenbeek A; Carde P; Meerwaldt JH; Somers R; Thomas J; De Bock R; Raemaekers JM; van Hoof A; De Wolf-Peeters C; van Glabbeke M
    J Clin Oncol; 1998 Jan; 16(1):41-7. PubMed ID: 9440721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon alpha consolidation after intensive chemotherapy does not prolong the progression-free survival of patients with low-grade non-Hodgkin's lymphoma: results of the Southwest Oncology Group randomized phase III study 8809.
    Fisher RI; Dana BW; LeBlanc M; Kjeldsberg C; Forman JD; Unger JM; Balcerzak SP; Gaynor ER; Roy V; Miller T
    J Clin Oncol; 2000 May; 18(10):2010-6. PubMed ID: 10811664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prednimustine, mitoxantrone (PmM) vs cyclophosphamide, vincristine, prednisone (COP) for the treatment of advanced low-grade non-Hodgkin's lymphoma. German Low-Grade Lymphoma Study Group.
    Unterhalt M; Herrmann R; Tiemann M; Parwaresch R; Stein H; Trümper L; Nahler M; Reuss-Borst M; Tirier C; Neubauer A; Freund M; Kreuser ED; Dietzfelbinger H; Bodenstein H; Engert A; Stauder R; Eimermacher H; Landys K; Hiddemann W
    Leukemia; 1996 May; 10(5):836-43. PubMed ID: 8656680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. alpha Interferon maintenance therapy in patients with low-grade non-Hodgkin's lymphomas after cytoreductive chemotherapy with prednimustine and mitoxantrone.
    Hiddemann W; Unterhalt M; Koch P; Nahler M; Herrmann R; van de Loo J
    Eur J Cancer; 1991; 27 Suppl 4():S37-9. PubMed ID: 1799474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of low-grade non-Hodgkin's lymphoma by cytoreductive chemotherapy with prednimustine/mitoxantrone followed by interferon alpha-2b maintenance: results of a clinical phase II study.
    Hiddemann W; Unterhalt M; Koch P; Nahler M; van de Loo J
    Semin Oncol; 1990 Dec; 17(6 Suppl 10):20-3. PubMed ID: 2259919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon alfa combined with cytotoxic chemotherapy for patients with non-Hodgkin's lymphoma.
    Smalley RV; Andersen JW; Hawkins MJ; Bhide V; O'Connell MJ; Oken MM; Borden EC
    N Engl J Med; 1992 Nov; 327(19):1336-41. PubMed ID: 1406835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Alpha interferon in therapy of non-Hodgkin's lymphoma].
    Freund M; Hanauske AR
    Onkologie; 1990 Dec; 13(6):424-8. PubMed ID: 2092278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase II trial of intermittent leukocyte interferon and high dose chlorambucil in the treatment of non-Hodgkin's lymphoma resistant to conventional therapy.
    Clark RH; Dimitrov NV; Axelson JA; Charamella LJ; Stott PB
    Am J Clin Oncol; 1989 Feb; 12(1):75-7. PubMed ID: 2912022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status and future perspectives in the treatment of low-grade non-Hodgkin's lymphomas.
    Hiddemann W; Unterhalt M
    Blood Rev; 1994 Dec; 8(4):225-33. PubMed ID: 7888829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of fludarabine and alpha-interferon in patients with low-grade non-Hodgkin's lymphoma.
    Morris GJ; Millenson MM; Padavic-Shaller K; Wang H; Rogatko A; Clyde J; Boyd RL; Yeslow G; Halbherr T; Schilder RJ; Smith MR
    Haematologica; 2004 Dec; 89(12):1484-91. PubMed ID: 15590399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Primary gastrointestinal non-Hodgkin's lymphoma in two Hungarian regions].
    Kollár B; Rajnics P; Hunyady B; Zeleznik E; Jakucs J; Egyed M
    Orv Hetil; 2009 Aug; 150(35):1649-53. PubMed ID: 19692309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete remission following recombinant interferon alpha-2a in a patient with diffuse large B cell cutaneous lymphoma.
    Tourani JM; Leaute JB; Lessana-Leibowitch M; Andrieu JM
    Nouv Rev Fr Hematol (1978); 1989; 31(4):315-6. PubMed ID: 2691984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The treatment of relapsed or refractory intermediate grade non-Hodgkin's lymphoma with autologous bone marrow transplantation followed by cyclosporine and interferon.
    Gryn J; Johnson E; Goldman N; Devereux L; Grana G; Hageboutros A; Fernandez E; Constantinou C; Harrer W; Viner E; Goldberg J
    Bone Marrow Transplant; 1997 Feb; 19(3):221-6. PubMed ID: 9028549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon alfa for the treatment of follicular lymphomas.
    Hiddemann W; Griesinger F; Unterhalt M
    Cancer J Sci Am; 1998 Jul; 4 Suppl 2():S13-8. PubMed ID: 9672770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma.
    Philip T; Armitage JO; Spitzer G; Chauvin F; Jagannath S; Cahn JY; Colombat P; Goldstone AH; Gorin NC; Flesh M
    N Engl J Med; 1987 Jun; 316(24):1493-8. PubMed ID: 3295541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose ifosfamide in combination with etoposide and epirubicin (IVE) in the treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacy.
    Proctor SJ; Taylor PR; Angus B; Wood K; Lennard AL; Lucraft H; Carey PJ; Stark A; Iqbal A; Haynes A; Russel N; Leonard RC; Culligan D; Conn J; Jackson GH
    Eur J Haematol Suppl; 2001 Jul; 64():28-32. PubMed ID: 11486397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment options for primary splenic low-grade non-Hodgkin's lymphomas.
    Musteata VG; Corcimaru IT; Iacovleva IA; Musteata LZ; Suharschii IS; Antoci LT
    Clin Lab Haematol; 2004 Dec; 26(6):397-401. PubMed ID: 15595997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.